Recently it was shown in several transgenic AD mouse models that genetic deletion of the C2 domain of Mfge8 resulted in reduced cerebral amyloid angiopathy and that medin enhances the aggregation of β-amyloid (Aβ) while colocalizing with Aβ plaques6. This evidence concerns the gene MFGE8 and Alzheimer disease.